Related Experiment Video

Updated: May 13, 2026

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles

Xingfang Su1, Nicole Yang, K Dane Wittrup

  • 1Department of Material Science and Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.

Biomacromolecules
|March 1, 2013
PubMed

Insights

This study introduces a two-stage cancer therapy approach using antibody-targeted gelonin toxin and polymer nanoparticles for enhanced cytosolic delivery into tumor cells. This method significantly boosts toxin efficacy while minimizing off-target toxicity.

Area of Science:

  • Biotechnology and Nanomedicine
  • Cancer Therapeutics
  • Molecular Delivery Systems

Background:

  • Plant-derived Type I toxins show promise as anticancer agents.
  • Effective cancer therapy requires targeted delivery of toxins into tumor cells.
  • Cytosolic delivery is crucial for the efficacy of many potent toxins like gelonin.

Purpose of the Study:

  • To develop and test a novel two-stage delivery system for plant-derived toxins.
  • To enhance the cytosolic delivery and efficacy of gelonin toxin in cancer cells.
  • To evaluate the potential for targeted cancer therapy with reduced off-target effects.

Main Methods:

  • Pre-coating tumor cells with antibody-targeted gelonin toxin.
  • Utilizing endosome-disrupting polymer nanoparticles for co-internalization.
  • Assessing the impact of nanoparticle co-delivery on gelonin's cytosolic access and efficacy.

Main Results:

  • Successful co-internalization of polymer nanoparticles and tumor cell-bound gelonin.
  • Demonstrated enhanced cytosolic delivery of gelonin toxin.
  • Achieved over 50-fold increase in gelonin toxin efficacy.

Conclusions:

  • The two-stage delivery approach significantly enhances the potency of gelonin toxin.
  • This strategy enables focused delivery of potent toxins to tumors.
  • The method holds potential for reducing off-target toxicity in cancer treatment.

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...